Skip to content

Using transcranial direct current stimulation (tDCS) to improve working memory in schizophrenia and healthy controls: investigating the role of current strength

Using transcranial direct current stimulation (tDCS) to improve working memory in schizophrenia and healthy controls: investigating the role of current strength at three time points post stimulation.

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12612001112853
Enrollment
36
Registered
2012-10-17
Start date
2010-05-31
Completion date
2013-02-01
Last updated
2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

Working memory is essential for key cognitive processes including reasoning, language comprehension and learning. Many neurological and psychiatric disorders result in working memory impairments and any technique that may enhance working memory would be very useful. For example cognitive dysfunction is a core feature of schizophrenia. The main areas affected include attention, memory and executive functioning; with working memory in particular frequently affected. These difficulties have been shown to negatively influence patients’ psychosocial functioning. Traditional treatment approaches have resulted in small gains at best. It is therefore essential that novel treatment approaches are explored. Recent research has suggested that brain stimulation, and in particular transcranial Direct Current Stimulation (tDCS), may have a role to play in improving cognition. While tDCS has been shown to improve working memory in a number of conditions, to date there have been no tDCS studies looking at the enhancement of working memory in schizophrenia. tDCS has been shown to be safe, with very few side effects. It involves the application of a very weak electrical current (1-2mA) using two surface electrodes (anode and cathode) to the head. The use of tDCS on the cortex has been shown to alter the how likely nerve cells are to fire and the effect generally has been shown to last up to 1 hour after stimulation. To date, a number of studies have examined the effect of tDCS on working memory, with some mixed results. While some studies have shown improvements in working memory during a session of tDCS (Boggio et al., 2006), other recent research has found no significant improvement (Marshall et al., 2005). A recent study has shown significantly better performance in a working memory task completed during an application of tDCS to the dorsolateral prefrontal cortex (DLPFC), a part of the brain associated with this type of thinking activity (Fregni et al., 2005). However, despite the breadth of tDCS research being undertaken, many questions remain regarding the most effective stimulation parameters, particularly with respect to optimal current strength (i.e. 1 or 2 mA). The current study aims investigate this in healthy participants and patients with schizophrenia.

Interventions

Anodal transcranial direct current stimulation (tDCS) at 1mA and 2mA intensity. This will be applied to the left dorsolateral prefrontal cortex for 20 minutes using a neuroConn GBH/Eldith DC Stimulator. tDCS will be delivered during three sessions (1mA tDCS, 2mA tDCS, and sham tDCS) that will be at least 48 hours apart

Sponsors

Dr Kate Hoy
Lead SponsorIndividual

Study design

Allocation
Randomised controlled trial
Intervention model
Crossover
Primary purpose
Treatment
Masking
Blinded (masking used)

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

This study will involve both patients with schizophrenia and healthy controls. As such inclusion and exclusion criteria are defined separately for these groups. Participants with schizophrenia will be included if they: - are voluntary and competent to consent - have a diagnosis of Schizophrenia or Schizoaffective Disorder as confirmed by the Structure Clinical Interview for the Diagnostic and Statistical Manual (DSM) -IV (SCID-IV) Healthy individuals will be included if they: - have capacity to consent - have no personal history of psychiatric illness (lifetime) - based on self report.

Exclusion criteria

Patients with schizophrenia will be excluded if they: - have a a DSM-IV history of substance abuse or dependence in the last 6 months - have a concomitant major and/or unstable medical or neurologic illness - are currently taking carbamazepine - are currently pregnant or lactating - have metal anywhere in the head, except the mouth (this includes metallic objects such as screws and clips from surgical procedures) Healthy participants will be excluded if they: - have an unstable medical condition, neurological disorder or are currently pregnant or lactating - have metal in the cranium, a pacemaker, cochlear implant medication pump or other electronic device

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 4, 2026